查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2151827

陰道微生物組診斷市場規模、佔有率和趨勢分析報告：按產品、技術、應用、最終用途、地區和細分市場預測（2026-2033 年）

Vaginal Microbiome Diagnostics Market Size, Share & Trends Analysis Report By Product, By Technology, By Application, By End-use, By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

陰道微生物組診斷市場概述

全球陰道微生物組診斷市場預計到 2025 年將達到 5.794 億美元，到 2026 年將成長到 6.596 億美元，到 2033 年將達到 17.273 億美元，2026 年至 2033 年的複合年成長率為 14.7%。

北美市場處於領先地位，預計到 2025 年將佔銷售額的 40.9%。市場成長的主要促進因素是細菌性陰道炎和陰道微生物群異常導致的高發病率、分子診斷技術的日益普及以及對準確、全面的陰道微生物組分析的需求不斷成長。

市場特徵和集中度

法規對市場有顯著影響，它會影響產品開發、臨床檢驗、商業化以及在醫療機構中的應用。在美國，用於輔助診斷陰道炎和細菌性陰道炎的核酸檢測系統由美國食品藥物管理局 (FDA) 監管，屬於 II 類體外診斷醫療設備，要求製造商證明其產品具有足夠的分析和臨床性能，並滿足適用的品質和標籤要求。

隨著企業將業務從集中式偵測擴展到分散式分子診斷，監管的考量變得尤為重要，同時也必須證明其易用性和工作流程效能。

隨著企業將檢測範圍從病原體鑑定擴展到有益微生物和腸道菌叢失調相關微生物的鑑定，產品組合正在重振全球市場。現代解決方案擴大將乳桿菌屬的檢測納入其中，此外還包括與細菌性陰道炎、念珠菌症、混合感染和復發性陰道疾病相關的微生物，從而能夠更全面地評估陰道微生物組的組成。定量分子技術和基於定序的方法進一步增強了從單一檢體中獲得的信息，從而能夠對陰道健康狀況進行更個性化的解讀。

例如，2026年7月，CirrusDx推出了“LacP”，這是一種乳酸桿菌檢測組合，旨在識別和定量維持陰道健康環境的關鍵乳酸桿菌菌種。這種將檢測範圍擴展到保護性微生物群落的檢測，標誌著其在以病原體為中心的傳統檢測方法之外取得了重大進展，並有助於評估腸道菌群異常和復發症狀。微生物檢測標靶、定量能力和臨床可解讀結果的持續擴展，可望進一步擴大陰道微生物組診斷的範圍。

隨著分子檢測、自取樣、數位化醫療和女性專屬健康服務的普及，陰道微生物組評估的可及性不斷擴大，區域擴張為陰道微生物組診斷產業創造了成長機會。北美受益於成熟的分子診斷基礎設施和參考檢查室網路，而歐洲和亞太地區預計將透過分子診斷能力的提升、生殖健康服務的增強以及個性化診斷的引入，實現進一步的擴張。將微生物組檢測與虛擬臨床護理相結合的夥伴關係可以進一步擴大可近性，使患者能夠擺脫傳統的面對面診斷途徑。例如，2025年6月，Organon和Evvy宣佈在美國建立合作關係，將Evvy的陰道微生物組檢測和臨床護理平台與「XACIATO」整合，為合格的細菌性陰道炎患者提供服務。

目錄

第1章：調查方法和範圍

第2章執行摘要

第3章：全球陰道微生物組診斷市場：變數、趨勢與範圍

  • 市場譜系展望
  • 市場動態
  • 全球陰道微生物組診斷市場分析工具

第4章：全球陰道微生物組診斷市場：產品特定估算與趨勢分析

  • 全球陰道微生物組診斷市場：產品特定趨勢分析
  • 2021年至2033年全球陰道微生物組診斷市場規模及產品趨勢分析
  • 裝置
  • 試劑和耗材
  • 軟體和服務

第5章：全球陰道微生物組診斷市場：依技術分類的估算與趨勢分析

  • 全球陰道微生物組診斷市場：依技術分類的趨勢分析
  • 全球陰道微生物組診斷市場：依技術分類的規模與趨勢分析（2021-2033年）
  • PCR/qPCR 和其他標靶核酸擴增方法
  • 次世代定序
  • 其他技術

第6章：全球陰道微生物組診斷市場：基於應用的估算與趨勢分析

  • 全球陰道微生物組診斷市場：按應用分類的趨勢
    • 全球陰道微生物組診斷市場：基於應用的規模和趨勢分析，2021-2033年
  • 細菌性陰道炎和陰道微生物群異常
  • 外陰陰道念珠菌症
  • 混合型和復發性陰道炎
  • 不孕不育、懷孕及生殖健康
  • 更年期與泌尿生殖系統症候群
  • 其他用途

第7章：全球陰道微生物組診斷市場：依最終用途分類的估算與趨勢分析

  • 全球陰道微生物組診斷市場：依最終用途分類的趨勢分析
    • 全球陰道微生物組診斷市場：依最終用途分類的規模和趨勢分析，2021-2033年
  • 醫院和診所
  • 診斷和檢測機構
  • 不孕不育及生殖醫學中心
  • 直接面對消費者
  • 其他最終用戶

第8章：陰道微生物組診斷市場：區域估算與趨勢分析

  • 區域儀錶板
  • 市場規模、預測與趨勢分析，2021-2033年
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • UAE
    • 科威特

第9章 競爭情勢

  • 公司和競爭對手的分類
  • 策略規劃
  • 企業市場占有率分析，2025 年
  • 主要認證機構/方案運營機構列表
  • 公司簡介列表
    • Hologic, Inc.
    • Quest Diagnostics Incorporated
    • Labcorp Holdings Inc.
    • Cepheid/Danaher Corporation
    • Becton, Dickinson and Company
    • Seegene, Inc.
    • Mayo Clinic Laboratories
    • F. Hoffmann-La Roche Ltd.
    • Evvy
    • Juno Bio
Product Code: GVR-4-68041-045-3

Vaginal Microbiome Diagnostics Market Summary

The global vaginal microbiome diagnostics market size was valued at USD 579.4 million in 2025 and is projected to grow from USD 659.6 million in 2026 to USD 1,727.3 million by 2033, at a CAGR of 14.7% from 2026 to 2033. North America dominated the market, accounting for the revenue share of 40.9% in 2025. Market growth is primarily driven by the high burden of bacterial vaginosis and vaginal dysbiosis, increasing adoption of molecular diagnostic technologies, and growing demand for accurate and comprehensive vaginal microbiome profiling.

Market Characteristics & Concentration

Regulations have a significant impact on the market by influencing product development, clinical validation, commercialization, and adoption across healthcare settings. In the U.S., nucleic acid detection systems intended to aid the diagnosis of vaginitis and bacterial vaginosis are regulated by the FDA as Class II in vitro diagnostic devices, requiring manufacturers to demonstrate appropriate analytical and clinical performance, along with applicable quality and labeling requirements.

Regulatory considerations become particularly important as companies expand from centralized laboratory testing toward decentralized molecular diagnostics, where usability and workflow performance must also be demonstrated.

Product expansion is strengthening the global market as companies broaden testing beyond pathogen identification to include the characterization of beneficial and dysbiosis-associated microorganisms. Newer solutions increasingly assess Lactobacillus species alongside organisms associated with bacterial vaginosis, candidiasis, mixed infections, and recurrent vaginal conditions, enabling a more comprehensive evaluation of vaginal microbial composition. Quantitative molecular methods and sequencing-based approaches can further expand the information obtained from a single specimen and support a more personalized interpretation of vaginal health.

For instance, in July 2026, CirrusDx launched LacP, a Lactobacillus panel designed to identify and quantify key Lactobacillus species the support a healthy vaginal environment. The expansion toward measuring protective microbial populations represents an important evolution beyond conventional pathogen-centered testing and can support the evaluation of dysbiosis and recurrent symptoms. Continued expansion of microbial targets, quantitative capabilities, and clinically interpreted results is expected to broaden the range of addressable applications for vaginal microbiome diagnostics.

Regional expansion is creating growth opportunities in the vaginal microbiome diagnostics industry as molecular testing, self-collection, digital healthcare, and specialized women's-health services increase access to vaginal microbiome assessment. North America benefits from an established molecular diagnostic infrastructure and reference laboratory networks, while Europe and the Asia Pacific offer expansion potential through improvements in molecular capabilities, reproductive health services, and the adoption of personalized diagnostics. Partnerships that connect microbiome testing with virtual clinical care can further increase access without requiring patients to follow exclusively conventional in-person diagnostic pathways. For instance, in June 2025, Organon and Evvy announced a U.S. collaboration integrating Evvy's vaginal microbiome testing and clinical-care platform with access to XACIATO for eligible patients diagnosed with bacterial vaginosis.

Global Vaginal Microbiome Diagnostics Market Report Segmentation

This report forecasts revenue growth at country levels and provides an analysis on the latest industry trends and opportunities in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global vaginal microbiome diagnostics market report based on the product, technology, application, end-use, and region:

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Instruments
  • Reagents & Consumables
  • Software & Services
  • Technology Outlook (Revenue, USD Million, 2021 - 2033)
  • PCR/qPCR & Other Targeted Nucleic Acid Amplification
  • Next-Generation Sequencing
  • Other Technologies
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Bacterial Vaginosis & Vaginal Dysbiosis
  • Vulvovaginal Candidiasis
  • Mixed & Recurrent Vaginitis
  • Fertility, Pregnancy & Reproductive Health
  • Menopause & Genitourinary Syndrome
  • Other Applications
  • End-use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals & Clinics
  • Diagnostic & Reference Laboratories
  • Fertility & Reproductive Health Centers
  • Direct-to-Consumer
  • Other End-uses
  • Regional Outlook (Revenue, USD Million; 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Norway
    • Denmark
    • Sweden
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
    • 1.2.1. Product Segment
    • 1.2.2. Technology Segment
    • 1.2.3. Application Segment
    • 1.2.4. End Use Segment
  • 1.3. Information analysis
    • 1.3.1. Market formulation & data visualization
  • 1.4. Data validation & publishing
  • 1.5. Information Procurement
    • 1.5.1. Primary Research
  • 1.6. Information or Data Analysis
  • 1.7. Market Formulation & Validation
  • 1.8. Market Model
  • 1.9. Total Market: CAGR Calculation
  • 1.10. Objectives
    • 1.10.1. Objective 1
    • 1.10.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Insights Landscape

Chapter 3. Global Vaginal Microbiome Diagnostics Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
    • 3.2.3. Market opportunity analysis
  • 3.3. Global Vaginal Microbiome Diagnostics Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis

Chapter 4. Global Vaginal Microbiome Diagnostics Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Vaginal Microbiome Diagnostics Market Product Movement Analysis
  • 4.3. Global Vaginal Microbiome Diagnostics Market Size & Trend Analysis by Product, 2021 to 2033 (USD Million)
  • 4.4. Instruments
    • 4.4.1. Instruments market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.5. Reagents & Consumables
    • 4.5.1. Reagents & Consumables market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.6. Software & Services
    • 4.6.1. Software & Services market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 5. Global Vaginal Microbiome Diagnostics Market: Technology Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Vaginal Microbiome Diagnostics Market Technology Movement Analysis
  • 5.3. Global Vaginal Microbiome Diagnostics Market Size & Trend Analysis, by Technology, 2021 to 2033 (USD Million)
  • 5.4. PCR/qPCR & Other Targeted Nucleic Acid Amplification
    • 5.4.1. PCR/qPCR & Other Targeted Nucleic Acid Amplification market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.5. Next-Generation Sequencing
    • 5.5.1. Next-Generation Sequencing market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.6. Other Technologies
    • 5.6.1. Other Technologies market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 6. Global Vaginal Microbiome Diagnostics Market: Application Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Vaginal Microbiome Diagnostics Market Application Movement Analysis
    • 6.2.1. Global Vaginal Microbiome Diagnostics Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
  • 6.3. Bacterial Vaginosis & Vaginal Dysbiosis
    • 6.3.1. Bacterial Vaginosis & Vaginal Dysbiosis market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.4. Vulvovaginal Candidiasis
    • 6.4.1. Vulvovaginal Candidiasis market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.5. Mixed & Recurrent Vaginitis
    • 6.5.1. Mixed & Recurrent Vaginitis market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.6. Fertility, Pregnancy & Reproductive Health
    • 6.6.1. Fertility, Pregnancy & Reproductive Health market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.7. Menopause & Genitourinary Syndrome
    • 6.7.1. Menopause & Genitourinary Syndrome market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.8. Other Applications
    • 6.8.1. Other Applications market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 7. Global Vaginal Microbiome Diagnostics Market: End Use Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Global Vaginal Microbiome Diagnostics Market End Use Movement Analysis
    • 7.2.1. Global Vaginal Microbiome Diagnostics Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
  • 7.3. Hospitals & Clinics
    • 7.3.1. Hospitals & Clinics market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.4. Diagnostic & Reference Laboratories
    • 7.4.1. Diagnostic & Reference Laboratories market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.5. Fertility & Reproductive Health Centers
    • 7.5.1. Fertility & Reproductive Health Centers market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.6. Direct-to-Consumer
    • 7.6.1. Direct-to-Consumer market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.7. Other End Users
    • 7.7.1. Other End Users market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 8. Vaginal Microbiome Diagnostics Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Dashboard
  • 8.2. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
  • 8.3. North America
    • 8.3.1. U.S.
      • 8.3.1.1. Key country dynamics
      • 8.3.1.2. Regulatory framework/ reimbursement structure
      • 8.3.1.3. Competitive scenario
      • 8.3.1.4. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.3.2. Canada
      • 8.3.2.1. Key country dynamics
      • 8.3.2.2. Regulatory framework/ reimbursement structure
      • 8.3.2.3. Competitive scenario
      • 8.3.2.4. Canada market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.3.3. Mexico
      • 8.3.3.1. Key country dynamics
      • 8.3.3.2. Regulatory framework/ reimbursement structure
      • 8.3.3.3. Competitive scenario
      • 8.3.3.4. Mexico market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.4. Europe
    • 8.4.1. UK
      • 8.4.1.1. Key country dynamics
      • 8.4.1.2. Regulatory framework/ reimbursement structure
      • 8.4.1.3. Competitive scenario
      • 8.4.1.4. UK market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.4.2. Germany
      • 8.4.2.1. Key country dynamics
      • 8.4.2.2. Regulatory framework/ reimbursement structure
      • 8.4.2.3. Competitive scenario
      • 8.4.2.4. Germany market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.4.3. France
      • 8.4.3.1. Key country dynamics
      • 8.4.3.2. Regulatory framework/ reimbursement structure
      • 8.4.3.3. Competitive scenario
      • 8.4.3.4. France market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.4.4. Italy
      • 8.4.4.1. Key country dynamics
      • 8.4.4.2. Regulatory framework/ reimbursement structure
      • 8.4.4.3. Competitive scenario
      • 8.4.4.4. Italy market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.4.5. Spain
      • 8.4.5.1. Key country dynamics
      • 8.4.5.2. Regulatory framework/ reimbursement structure
      • 8.4.5.3. Competitive scenario
      • 8.4.5.4. Spain market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.4.6. Norway
      • 8.4.6.1. Key country dynamics
      • 8.4.6.2. Regulatory framework/ reimbursement structure
      • 8.4.6.3. Competitive scenario
      • 8.4.6.4. Norway market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.4.7. Sweden
      • 8.4.7.1. Key country dynamics
      • 8.4.7.2. Regulatory framework/ reimbursement structure
      • 8.4.7.3. Competitive scenario
      • 8.4.7.4. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.4.8. Denmark
      • 8.4.8.1. Key country dynamics
      • 8.4.8.2. Regulatory framework/ reimbursement structure
      • 8.4.8.3. Competitive scenario
      • 8.4.8.4. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.5. Asia Pacific
    • 8.5.1. Japan
      • 8.5.1.1. Key country dynamics
      • 8.5.1.2. Regulatory framework/ reimbursement structure
      • 8.5.1.3. Competitive scenario
      • 8.5.1.4. Japan market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.5.2. China
      • 8.5.2.1. Key country dynamics
      • 8.5.2.2. Regulatory framework/ reimbursement structure
      • 8.5.2.3. Competitive scenario
      • 8.5.2.4. China market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.5.3. India
      • 8.5.3.1. Key country dynamics
      • 8.5.3.2. Regulatory framework/ reimbursement structure
      • 8.5.3.3. Competitive scenario
      • 8.5.3.4. India market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.5.4. Australia
      • 8.5.4.1. Key country dynamics
      • 8.5.4.2. Regulatory framework/ reimbursement structure
      • 8.5.4.3. Competitive scenario
      • 8.5.4.4. Australia market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.5.5. South Korea
      • 8.5.5.1. Key country dynamics
      • 8.5.5.2. Regulatory framework/ reimbursement structure
      • 8.5.5.3. Competitive scenario
      • 8.5.5.4. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.5.6. Thailand
      • 8.5.6.1. Key country dynamics
      • 8.5.6.2. Regulatory framework/ reimbursement structure
      • 8.5.6.3. Competitive scenario
      • 8.5.6.4. Thailand market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.6. Latin America
    • 8.6.1. Brazil
      • 8.6.1.1. Key country dynamics
      • 8.6.1.2. Regulatory framework/ reimbursement structure
      • 8.6.1.3. Competitive scenario
      • 8.6.1.4. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.6.2. Argentina
      • 8.6.2.1. Key country dynamics
      • 8.6.2.2. Regulatory framework/ reimbursement structure
      • 8.6.2.3. Competitive scenario
      • 8.6.2.4. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.7. MEA
    • 8.7.1. South Africa
      • 8.7.1.1. Key country dynamics
      • 8.7.1.2. Regulatory framework/ reimbursement structure
      • 8.7.1.3. Competitive scenario
      • 8.7.1.4. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.7.2. Saudi Arabia
      • 8.7.2.1. Key country dynamics
      • 8.7.2.2. Regulatory framework/ reimbursement structure
      • 8.7.2.3. Competitive scenario
      • 8.7.2.4. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.7.3. UAE
      • 8.7.3.1. Key country dynamics
      • 8.7.3.2. Regulatory framework/ reimbursement structure
      • 8.7.3.3. Competitive scenario
      • 8.7.3.4. UAE market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.7.4. Kuwait
      • 8.7.4.1. Key country dynamics
      • 8.7.4.2. Regulatory framework/ reimbursement structure
      • 8.7.4.3. Competitive scenario
      • 8.7.4.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Company/Competition Categorization
  • 9.2. Strategy Mapping
  • 9.3. Company Market Share Analysis, 2025
  • 9.4. List of Key Certification Providers/Scheme Owners
  • 9.5. Company Profiles/Listing
    • 9.5.1. Hologic, Inc.
      • 9.5.1.1. Company overview
      • 9.5.1.2. Financial performance
      • 9.5.1.3. Product benchmarking
      • 9.5.1.4. Strategic initiatives
    • 9.5.2. Quest Diagnostics Incorporated
      • 9.5.2.1. Company overview
      • 9.5.2.2. Financial performance
      • 9.5.2.3. Product benchmarking
      • 9.5.2.4. Strategic initiatives
    • 9.5.3. Labcorp Holdings Inc.
      • 9.5.3.1. Company overview
      • 9.5.3.2. Financial performance
      • 9.5.3.3. Product benchmarking
      • 9.5.3.4. Strategic initiatives
    • 9.5.4. Cepheid / Danaher Corporation
      • 9.5.4.1. Company overview
      • 9.5.4.2. Financial performance
      • 9.5.4.3. Product benchmarking
      • 9.5.4.4. Strategic initiatives
    • 9.5.5. Becton, Dickinson and Company
      • 9.5.5.1. Company overview
      • 9.5.5.2. Financial performance
      • 9.5.5.3. Product benchmarking
      • 9.5.5.4. Strategic initiatives
    • 9.5.6. Seegene, Inc.
      • 9.5.6.1. Company overview
      • 9.5.6.2. Financial performance
      • 9.5.6.3. Product benchmarking
      • 9.5.6.4. Strategic initiatives
    • 9.5.7. Mayo Clinic Laboratories
      • 9.5.7.1. Company overview
      • 9.5.7.2. Financial performance
      • 9.5.7.3. Product benchmarking
      • 9.5.7.4. Strategic initiatives
    • 9.5.8. F. Hoffmann-La Roche Ltd.
      • 9.5.8.1. Company overview
      • 9.5.8.2. Financial performance
      • 9.5.8.3. Product benchmarking
      • 9.5.8.4. Strategic initiatives
    • 9.5.9. Evvy
      • 9.5.9.1. Company overview
      • 9.5.9.2. Financial performance
      • 9.5.9.3. Product benchmarking
      • 9.5.9.4. Strategic initiatives
    • 9.5.10. Juno Bio
      • 9.5.10.1. Company overview
      • 9.5.10.2. Financial performance
      • 9.5.10.3. Product benchmarking
      • 9.5.10.4. Strategic initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviation
  • Table 3 Global Vaginal Microbiome Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 4 Global Vaginal Microbiome Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
  • Table 5 Global Vaginal Microbiome Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 6 Global Vaginal Microbiome Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 7 North America Vaginal Microbiome Diagnostics Market, By Region, 2021 - 2033 (USD Million)
  • Table 8 North America Vaginal Microbiome Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 9 North America Vaginal Microbiome Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
  • Table 10 North America Vaginal Microbiome Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 11 North America Vaginal Microbiome Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 12 U.S. Vaginal Microbiome Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 13 U.S. Vaginal Microbiome Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
  • Table 14 U.S. Vaginal Microbiome Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 15 U.S. Vaginal Microbiome Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 16 Canada Vaginal Microbiome Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 17 Canada Vaginal Microbiome Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
  • Table 18 Canada Vaginal Microbiome Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 19 Canada Vaginal Microbiome Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 20 Mexico Vaginal Microbiome Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 21 Mexico Vaginal Microbiome Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
  • Table 22 Mexico Vaginal Microbiome Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 23 Mexico Vaginal Microbiome Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 24 Europe Vaginal Microbiome Diagnostics Market, By Region, 2021 - 2033 (USD Million)
  • Table 25 Europe Vaginal Microbiome Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 26 Europe Vaginal Microbiome Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
  • Table 27 Europe Vaginal Microbiome Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 28 Europe Vaginal Microbiome Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 29 UK Vaginal Microbiome Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 30 UK Vaginal Microbiome Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
  • Table 31 UK Vaginal Microbiome Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 32 UK Vaginal Microbiome Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 33 Germany Vaginal Microbiome Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 34 Germany Vaginal Microbiome Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
  • Table 35 Germany Vaginal Microbiome Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 36 Germany Vaginal Microbiome Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 37 France Vaginal Microbiome Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 38 France Vaginal Microbiome Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
  • Table 39 France Vaginal Microbiome Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 40 France Vaginal Microbiome Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 41 Italy Vaginal Microbiome Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 42 Italy Vaginal Microbiome Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
  • Table 43 Italy Vaginal Microbiome Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 44 Italy Vaginal Microbiome Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 45 Spain Vaginal Microbiome Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 46 Spain Vaginal Microbiome Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
  • Table 47 Spain Vaginal Microbiome Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 48 Spain Vaginal Microbiome Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 49 Denmark Vaginal Microbiome Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 50 Denmark Vaginal Microbiome Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
  • Table 51 Denmark Vaginal Microbiome Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 52 Denmark Vaginal Microbiome Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 53 Sweden Vaginal Microbiome Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 54 Sweden Vaginal Microbiome Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
  • Table 55 Sweden Vaginal Microbiome Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 56 Sweden Vaginal Microbiome Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 57 Norway Vaginal Microbiome Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 58 Norway Vaginal Microbiome Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
  • Table 59 Norway Vaginal Microbiome Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 60 Norway Vaginal Microbiome Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 61 Asia Pacific Vaginal Microbiome Diagnostics Market, By Region, 2021 - 2033 (USD Million)
  • Table 62 Asia Pacific Vaginal Microbiome Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 63 Asia Pacific Vaginal Microbiome Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
  • Table 64 Asia Pacific Vaginal Microbiome Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 65 Asia Pacific Vaginal Microbiome Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 66 Japan Vaginal Microbiome Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 67 Japan Vaginal Microbiome Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
  • Table 68 Japan Vaginal Microbiome Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 69 Japan Vaginal Microbiome Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 70 China Vaginal Microbiome Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 71 China Vaginal Microbiome Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
  • Table 72 China Vaginal Microbiome Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 73 China Vaginal Microbiome Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 74 India Vaginal Microbiome Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 75 India Vaginal Microbiome Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
  • Table 76 India Vaginal Microbiome Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 77 India Vaginal Microbiome Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 78 Australia Vaginal Microbiome Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 79 Australia Vaginal Microbiome Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
  • Table 80 Australia Vaginal Microbiome Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 81 Australia Vaginal Microbiome Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 82 South Korea Vaginal Microbiome Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 83 South Korea Vaginal Microbiome Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
  • Table 84 South Korea Vaginal Microbiome Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 85 South Korea Vaginal Microbiome Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 86 Thailand Vaginal Microbiome Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 87 Thailand Vaginal Microbiome Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
  • Table 88 Thailand Vaginal Microbiome Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 89 Thailand Vaginal Microbiome Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 90 Latin America Vaginal Microbiome Diagnostics Market, By Region, 2021 - 2033 (USD Million)
  • Table 91 Latin America Vaginal Microbiome Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 92 Latin America Vaginal Microbiome Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
  • Table 93 Latin America Vaginal Microbiome Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 94 Latin America Vaginal Microbiome Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 95 Brazil Vaginal Microbiome Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 96 Brazil Vaginal Microbiome Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
  • Table 97 Brazil Vaginal Microbiome Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 98 Brazil Vaginal Microbiome Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 99 Argentina Vaginal Microbiome Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 100 Argentina Vaginal Microbiome Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
  • Table 101 Argentina Vaginal Microbiome Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 102 Argentina Vaginal Microbiome Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 103 MEA Vaginal Microbiome Diagnostics Market, By Region, 2021 - 2033 (USD Million)
  • Table 104 MEA Vaginal Microbiome Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 105 MEA Vaginal Microbiome Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
  • Table 106 MEA Vaginal Microbiome Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 107 MEA Vaginal Microbiome Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 108 South Africa Vaginal Microbiome Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 109 South Africa Vaginal Microbiome Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
  • Table 110 South Africa Vaginal Microbiome Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 111 South Africa Vaginal Microbiome Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 112 Saudi Arabia Vaginal Microbiome Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 113 Saudi Arabia Vaginal Microbiome Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
  • Table 114 Saudi Arabia Vaginal Microbiome Diagnostics Market, By Application, 2021-2033 (USD Million)
  • Table 115 Saudi Arabia Vaginal Microbiome Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 116 UAE Vaginal Microbiome Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 117 UAE Vaginal Microbiome Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
  • Table 118 UAE Vaginal Microbiome Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 119 Kuwait Vaginal Microbiome Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 120 Kuwait Vaginal Microbiome Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
  • Table 121 Kuwait Vaginal Microbiome Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 122 Kuwait Vaginal Microbiome Diagnostics Market, By End Use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modelling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Vaginal Microbiome Diagnostics Market: Market outlook
  • Fig. 9 Vaginal Microbiome Diagnostics Market: Competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Vaginal microbiome diagnostics market driver impact
  • Fig. 15 Vaginal microbiome diagnostics market restraint impact
  • Fig. 16 Vaginal microbiome diagnostics market strategic initiatives analysis
  • Fig. 17 Vaginal microbiome diagnostics market: Product movement analysis
  • Fig. 18 Vaginal microbiome diagnostics market: Product outlook and key takeaways
  • Fig. 19 Reagents & Consumables & systems market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 20 Instruments market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 21 Software & Services market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 22 Vaginal microbiome diagnostics market: Technology movement analysis
  • Fig. 23 Vaginal microbiome diagnostics market: Technology outlook and key takeaways
  • Fig. 24 PCR/qPCR & Other Targeted Nucleic Acid Amplification market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 25 Next-Generation Sequencing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 26 Other Technologies market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 27 Vaginal microbiome diagnostics market: Application movement analysis
  • Fig. 28 Vaginal microbiome diagnostics market: Application outlook and key takeaways
  • Fig. 29 Bacterial Vaginosis & Vaginal Dysbiosis market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 30 Vulvovaginal Candidiasis market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 31 Mixed & Recurrent Vaginitis market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 32 Fertility, Pregnancy & Reproductive Health market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 33 Menopause & Genitourinary Syndrome market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 34 Other Applications market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 35 Vaginal microbiome diagnostics market: End Use movement analysis
  • Fig. 36 Vaginal microbiome diagnostics market: End Use outlook and key takeaways
  • Fig. 37 Academic & research institutes market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 38 Hospitals & diagnostic labs market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 39 Pharma & biotech companies market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 40 Direct-to-Consumer market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 41 Other End Users market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 42 Global Vaginal microbiome diagnostics market: Regional movement analysis
  • Fig. 43 Global Vaginal microbiome diagnostics market: Regional outlook and key takeaways
  • Fig. 44 North America market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 45 U.S. market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 46 Canada market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 47 Mexico market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 48 Europe market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 49 UK market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 50 Germany market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 51 France market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 52 Italy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 53 Spain market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 54 Sweden market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 55 Norway market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 56 Denmark market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 57 Asia Pacific market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 58 Japan market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 59 China market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 60 India market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 61 Australia market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 62 Thailand market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 63 South Korea market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 64 Latin America market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 65 Brazil market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 66 Argentina market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 67 Middle East and Africa. market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 68 Saudi Arabia market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 69 South Africa market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 70 UAE market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 71 Kuwait market estimates and forecasts, 2021 - 2033 (USD Million)